Trial Profile
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Lutropin alfa (Primary) ; Cetrorelix; Choriogonadotropin alfa; Recombinant follicle-stimulating hormone
- Indications Female infertility
- Focus Therapeutic Use
- 05 Jan 2010 New trial record